Jennifer Doudna to speak on ethics, future of CRISPR

Jennifer Doudna, who pioneered the gene-editing technology known as CRISPR-Cas9, will come to Stanford to discuss the ethics and future applications of the tool.

Jennifer Doudna

Jennifer Doudna, PhD, a pioneer of the powerful gene-editing tool CRISPR-Cas9, will speak at 1 p.m. Oct. 9 in Berg Hall at the Li Ka Shing Center for Learning and Knowledge.

In her talk, “World of CRISPR: Editing Genomes and Altering our Future,” Doudna, a professor of chemistry and of biochemistry and molecular biology at the University of California-Berkeley, will cover the basic biology that inspired CRISPR-Cas9 and discuss how the gene-editing tool is being used in labs around the world, and how it may come to bear on the future of medicine. She will also speak to the ethical challenges surrounding CRISPR, focusing on how scientific and medical decisions today could affect generations in the future.

The event, which is free and open to the public, is part of the Molecular Imaging Program at Stanford’s IMAGinING THE FUTURE seminar series.

 



Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.